Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 72-78, 15 December 2009

Brain dysfunction in multiple chemical sensitivity

  • Ramon Orriols

      Affiliations

    • Servei de Pneumologia, Hospital Universitari Vall d' Hebron, Barcelona, Catalonia, Spain
    • CIBER Enfermedades Respiratorias (CIBERES), Spain
    • Corresponding Author InformationCorresponding author. Servei de Pneumologia, Hospital Universitari Vall d'Hebron, Passeig Vall d' Hebron, 119-129, 08035 Barcelona, Catalonia, Spain. Tel.: +34 93 27461; fax: +34 93 2746803.
  • ,
  • Roser Costa

      Affiliations

    • Servei de Pneumologia, Hospital Universitari Vall d' Hebron, Barcelona, Catalonia, Spain
    • Servei de Pneumologia, Hospital Mutua de Terrassa, Terrassa, Catalonia, Spain
    • Facultat de Medicina, Universitat Autònoma de Barcelona, Catalonia, Spain
  • ,
  • Gemma Cuberas

      Affiliations

    • Servei de Medicina Nuclear, Hospital Universitari Vall d' Hebron, Barcelona, Catalonia, Spain
  • ,
  • Carlos Jacas

      Affiliations

    • Servei de Medicina Interna, Hospital Universitari Vall d' Hebron, Barcelona, Catalonia, Spain
  • ,
  • Joan Castell

      Affiliations

    • Servei de Medicina Nuclear, Hospital Universitari Vall d' Hebron, Barcelona, Catalonia, Spain
  • ,
  • Jordi Sunyer

      Affiliations

    • Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Catalonia, Spain
    • Municipal Institute of Medical Research (IMIM-Hospital del Mar), Barcelona, Catalonia, Spain
    • CIBER Epidemiologia y Salud Pública (CIBERESP), Spain

Received 27 January 2009; received in revised form 4 August 2009; accepted 3 September 2009. published online 05 October 2009.

Abstract 

Multiple Chemical Sensitivity (MCS) is a chronic acquired disorder of unknown pathogenesis. The aim of this study was to ascertain whether MCS patients present brain single photon emission computed tomography (SPECT) and psychometric scale changes after a chemical challenge. This procedure was performed with chemical products at non-toxic concentrations in 8 patients diagnosed with MCS and in their healthy controls. In comparison to controls, cases presented basal brain SPECT hypoperfusion in small cortical areas of the right parietal and both temporal and fronto-orbital lobes. After chemical challenge, cases showed hypoperfusion in the olfactory, right and left hippocampus, right parahippocampus, right amygdala, right thalamus, right and left Rolandic and right temporal cortex regions(p0.01). By contrast, controls showed hyperperfusion in the cingulus, right parahippocampus, left thalamus and some cortex regions (p0.01). The clustered deactivation pattern in cases was stronger than in controls (p=0.012) and the clustered activation pattern in controls was higher than in cases (p=0.012). In comparison to controls, cases presented poorer quality of life and neurocognitive function at baseline, and neurocognitive worsening after chemical exposure.

Chemical exposure caused neurocognitive impairment, and SPECT brain dysfunction particularly in odor-processing areas, thereby suggesting a neurogenic origin of MCS.

Keywords: Multiple chemical sensitivity, Environmental illness, Chemical challenge, Brain SPECT, Neuropsychological evaluation, Dysfunctional cognition

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(09)00845-4

doi:10.1016/j.jns.2009.09.003

Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 72-78, 15 December 2009